FR2414507A1 - Trans or 21-epi-eburnamonine - for treatment of cerebral oxygenation insufficiency has superior therapeutic index to vincamine and vincamone - Google Patents

Trans or 21-epi-eburnamonine - for treatment of cerebral oxygenation insufficiency has superior therapeutic index to vincamine and vincamone

Info

Publication number
FR2414507A1
FR2414507A1 FR7800969A FR7800969A FR2414507A1 FR 2414507 A1 FR2414507 A1 FR 2414507A1 FR 7800969 A FR7800969 A FR 7800969A FR 7800969 A FR7800969 A FR 7800969A FR 2414507 A1 FR2414507 A1 FR 2414507A1
Authority
FR
France
Prior art keywords
eburnamonine
epi
insufficiency
trans
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR7800969A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Omnium Chimique SA
Original Assignee
Omnium Chimique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omnium Chimique SA filed Critical Omnium Chimique SA
Priority to FR7800969A priority Critical patent/FR2414507A1/en
Priority to BE192811A priority patent/BE873373A/en
Publication of FR2414507A1 publication Critical patent/FR2414507A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Trans-eburnamonine or 21-epi-eburnamonine of formula (I) and its acid addition salts are new. Used in treatment of cerebral oxygeneration insufficiency by oral administration of unit doses of 10-30 mg (I) to give a daily dose of 10-100mg.
FR7800969A 1978-01-13 1978-01-13 Trans or 21-epi-eburnamonine - for treatment of cerebral oxygenation insufficiency has superior therapeutic index to vincamine and vincamone Pending FR2414507A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR7800969A FR2414507A1 (en) 1978-01-13 1978-01-13 Trans or 21-epi-eburnamonine - for treatment of cerebral oxygenation insufficiency has superior therapeutic index to vincamine and vincamone
BE192811A BE873373A (en) 1978-01-13 1979-01-10 TRANS-EBURNAMONINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7800969A FR2414507A1 (en) 1978-01-13 1978-01-13 Trans or 21-epi-eburnamonine - for treatment of cerebral oxygenation insufficiency has superior therapeutic index to vincamine and vincamone

Publications (1)

Publication Number Publication Date
FR2414507A1 true FR2414507A1 (en) 1979-08-10

Family

ID=9203441

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7800969A Pending FR2414507A1 (en) 1978-01-13 1978-01-13 Trans or 21-epi-eburnamonine - for treatment of cerebral oxygenation insufficiency has superior therapeutic index to vincamine and vincamone

Country Status (2)

Country Link
BE (1) BE873373A (en)
FR (1) FR2414507A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2529553A1 (en) * 1982-06-30 1984-01-06 Richter Gedeon Vegyeszet EBURNANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NV6013/65 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2529553A1 (en) * 1982-06-30 1984-01-06 Richter Gedeon Vegyeszet EBURNANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
BE873373A (en) 1979-05-02

Similar Documents

Publication Publication Date Title
FI920956A0 (en) DOSERINGSFORM FOER ADMINISTRERING AV ORAL HYPOGLYKEMISK GLIPISID.
IE790951L (en) Carnitine solution
GB8326878D0 (en) Administering medicaments to patients
GB8602264D0 (en) Administering medicaments to patients
EP0465508A4 (en) Dietary supplement for insulin-resistant diabetics
ZA763707B (en) A device for administering an anaesthetic to a patient
PT66789B (en) Process for the preparation of pharmaceutical compositionshaving high rate of resorption from heart glicosides for itself hardly resorptive to be parenterically administered
ES8705371A1 (en) Aminopropanol derivatives, process for their preparation, their use and medicines containing them.
ES472847A1 (en) 2-Bromo-ergosine and its acid addition salts, method for its preparation and its application as a medicine.
KR910005858A (en) Fatty acid therapy
DE3478749D1 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
EP0388799A3 (en) Use of human interferon-beta for stimulation of erythropoieses
FR2414507A1 (en) Trans or 21-epi-eburnamonine - for treatment of cerebral oxygenation insufficiency has superior therapeutic index to vincamine and vincamone
ZA936300B (en) Use of L-carnitine and acyl L-carnitines for treating patients suffering from AIDS and AIDS-related syndromes and asymptomatic HIV-seropositive patients
FR2155927A1 (en) 1-phenylcyclo hexane carboxylic acid esters - with antispasmodic and anticholinergic activity
ES8205190A1 (en) 3,7,11,15-Tetramethyl- 2,4,6,10,14-hexadecapentaenoic Acid
MY100483A (en) Niflumic acid morpholinoethyl ester diniflumate, preparation, use in therapeutics as analgesic and anti- inflammatory
ES8400731A1 (en) Derivatives of 3-phenoxy-3-propanol, their preparation and their therapeutic use.
PT78608A (en) Process for preparing a composition to promote the absorption of medicaments administered via rectum
MY101916A (en) Etoposide oral dosage form.
DE3369327D1 (en) Pharmaceutical compounds, preparation, use and intermediates therefor and their preparation
EP0212310A3 (en) Use of probucol in the preparation of a medicament for the treatment of heart arrhythmia
FR2447368A1 (en) PHENYLETHYLAMINE DERIVATIVES, THEIR PREPARATION AND MEDICAMENT CONTAINING THESE SUBSTANCES
SU1168252A1 (en) Method of treatment of patients ill with psoriasis
FR2201898A1 (en) Vincamine arabogalactan sulphate - with prolonged activity for treating cerebrovascular disorders